GET THE APP

The Impact of Elevated Nicotine Dosage on Peak Anaerobic Performance and Subjective Pain Perception in Non-smoking, Physically Active Individuals
..

Journal of Sports Medicine & Doping Studies

ISSN: 2161-0673

Open Access

Brief Report - (2023) Volume 13, Issue 5

The Impact of Elevated Nicotine Dosage on Peak Anaerobic Performance and Subjective Pain Perception in Non-smoking, Physically Active Individuals

Simen Hughes*
*Correspondence: Simen Hughes, Department of Physical Education, Charles University, 116 39 Prague, Czech Republic, Email:
Department of Physical Education, Charles University, 116 39 Prague, Czech Republic

Received: 04-Sep-2023, Manuscript No. jsmds-23-114905; Editor assigned: 06-Sep-2023, Pre QC No. P-114905; Reviewed: 18-Sep-2023, QC No. Q-114905; Revised: 23-Sep-2023, Manuscript No. R-114905; Published: 30-Sep-2023 , DOI: 10.37421/2161-0673.2023.13.324
Citation: Hughes, Simen. “The Impact of Elevated Nicotine Dosage on Peak Anaerobic Performance and Subjective Pain Perception in Nonsmoking, Physically Active Individuals.” J Sports Med Doping Stud 13 (2023): 324.
Copyright: © 2023 Hughes S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

The relationship between nicotine, a potent psychostimulant found in tobacco products and athletic performance has garnered increasing attention in recent years. While the adverse health effects of smoking are well-documented, the isolated impact of nicotine itself remains a subject of scientific inquiry. In this study, we delve into the complex interplay between nicotine and athletic performance, focusing on peak anaerobic capabilities and subjective pain perception [1]. Of particular interest is how elevated nicotine dosages affect these aspects in a cohort of non-smoking, physically active individuals. The use of nicotine-containing products, such as e-cigarettes and nicotine replacement therapies, has gained popularity among athletes seeking potential performance advantages. However, the physiological and perceptual responses to elevated nicotine levels remain poorly understood, making it imperative to investigate these effects comprehensively. By scrutinizing the influence of nicotine on anaerobic performance and pain perception, we aim to provide insights that can inform athletes, coaches and healthcare professionals about the potential risks and benefits associated with nicotine use in the context of sport [2,3].

Description

To explore the impact of elevated nicotine dosages on peak anaerobic performance and subjective pain perception, we conducted a controlled, double-blind study involving a diverse group of non-smoking, physically active individuals. Participants were randomly assigned to receive either a placebo or nicotine administration in carefully calibrated doses. The study included a rigorous assessment of anaerobic performance using established protocols such as sprint tests, agility exercises and strength assessments [4]. Concurrently, participants were subjected to pain-inducing exercises to gauge their subjective pain perception. These exercises ranged from isometric contractions to muscular endurance tasks, allowing us to capture the participants' pain tolerance and perception under the influence of nicotine. Furthermore, we monitored physiological parameters, including heart rate, blood pressure and blood oxygen levels, to gain a comprehensive understanding of how nicotine may influence the body's responses during peak exertion [5].

Conclusion

The outcomes of our investigation reveal intriguing insights into the impact of elevated nicotine dosages on anaerobic performance and subjective pain perception in non-smoking, physically active individuals. Our findings demonstrate that nicotine does have the potential to modulate these aspects, albeit with nuanced effects that vary among individuals. While some participants experienced enhancements in anaerobic performance and perceived pain reduction with nicotine administration, others displayed no significant changes or even performance decrements. These diverse responses underscore the complexity of nicotine's influence on athletic performance. In conclusion, this study highlights the need for caution and careful consideration among athletes contemplating nicotine use for performance enhancement. The effects of nicotine are multifaceted and individualized and its use should be approached with a thorough understanding of its potential benefits and risks. Furthermore, our findings underscore the importance of continued research in this domain to provide athletes, coaches and healthcare professionals with evidence-based guidance for responsible and informed decision-making regarding nicotine use in sports.

Acknowledgement

None.

Conflict of Interest

There are no conflicts of interest by author.

References

  1. Aguilar-Navarro, Millán, Gloria Muñoz, Juan José Salinero and Jesús Muñoz-Guerra, et al. "Urine caffeine concentration in doping control samples from 2004 to 2015." Nutrients 11 (2019): 286.

    Google Scholar, Crossref, Indexed at

  2. Jiménez, Sergio L., Javier Díaz-Lara, Helios Pareja-Galeano and Juan Del Coso. "Caffeinated drinks and physical performance in sport: A systematic review." Nutrients 13 (2021): 2944.

    Google Scholar, Crossref, Indexed at

  3. Hudson, Geoffrey M., J. Matt Green, Phillip A. Bishop and Mark T. Richardson. "Effects of caffeine and aspirin on light resistance training performance, perceived exertion and pain perception." J Strength Cond Res 22 (2008): 1950-1957.

    Google Scholar, Crossref, Indexed at

  4. Tscholl, Philippe, Juan M. Alonso, Gabriel Dollé and Astrid Junge, et al. "The use of drugs and nutritional supplements in top-level track and field athletes." m J Sports Med 38 (2010): 133-140.

    Google Scholar, Crossref, Indexed at

  5. Prakash, Suraj, Radha, Manoj Kumar and Neeraj Kumari, et al. "Plant-based antioxidant extracts and compounds in the management of oral cancer." Antioxidants 10 (2021): 1358.

    Google Scholar, Crossref

Google Scholar citation report
Citations: 1022

Journal of Sports Medicine & Doping Studies received 1022 citations as per Google Scholar report

Journal of Sports Medicine & Doping Studies peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward